Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
The long-term implantable E3 CGM system now approved for commercialization in select European markets GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE...